HPE
63
2
PPL
57
-2
XYL
58
2
SWK
39
-10
NAVI
49
2
SPG
41
3
RL
56
-3
ICE
52
2
STI
35
-5
CME
46
3
AON
62
2
MPC
63
-5
PSX
57
-7
HCA
44
-4
PFG
53
8
HON
72
2
BSX
63
-3
ECL
59
5
CA
9
-3
EIX
42
5
HPE
63
2
PPL
57
-2
XYL
58
2
SWK
39
-10
NAVI
49
2
SPG
41
3
RL
56
-3
ICE
52
2
STI
35
-5
CME
46
3
AON
62
2
MPC
63
-5
PSX
57
-7
HCA
44
-4
PFG
53
8
HON
72
2
BSX
63
-3
ECL
59
5
CA
9
-3
EIX
42
5
Financhill
Back

ProShares UltraShort Bloomberg Crude Oil Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
34

SCO
ProShares UltraShort Bloomberg Crude Oil

Last Price:
$16.83
Seasonality Move:
-6.45%
Sell
46

SRPT
Sarepta Therapeutics

Last Price:
$21.81
Seasonality Move:
29.39%
Sell
34
ProShares UltraShort Bloomberg Crude Oil (SCO) is a Sell

Is ProShares UltraShort Bloomberg Crude Oil a Buy, Sell or Hold?

  • The current ProShares UltraShort Bloomberg Crude Oil [SCO] share price is $17.12. The Score for SCO is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • SCO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $18.38. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SCO Stock Price Chart

What is ProShares UltraShort Bloomberg Crude Oil's stock price today?

  • The ProShares UltraShort Bloomberg Crude Oil share price today is $17.12
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SCO is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $18.38
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

SCO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.62 Buy
Relative Strength Index (14 RSI): 46.68 Sell
Chaikin Money Flow: -1421945 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16 - 17.98) Buy
Bollinger Bands (100): (17.05 - 20.65) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.08 Buy
Relative Strength Index (14 RSI): 31.79 Sell
Chaikin Money Flow: 7064730 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (14.71 - 28.77) Sell
Bollinger Bands (100): (25.12 - 81.7) Sell

SCO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.86 Buy
20-day SMA: 16.95 Buy
50-day SMA: 18.58 Sell
200-day SMA: 18.09 Sell
8-day EMA: 14.01 Buy
20-day EMA: 8.5 Buy
50-day EMA: 4.12 Buy
200-day EMA: 1.14 Buy

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.6 Sell
20-day SMA: 18.6 Sell
50-day SMA: 30.56 Sell
200-day SMA: 87.14 Sell
8-day EMA: 15.43 Buy
20-day EMA: 9.43 Buy
50-day EMA: 4.58 Buy
200-day EMA: 1.27 Buy

ProShares UltraShort Bloomberg Crude Oil Earnings Growth & SCO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.77 per share, a decrease this year of $5.77 per share, and an increase next year of $5.30 per share.

ProShares UltraShort Bloomberg Crude Oil Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):